What is the appropriate management for a 74-year-old woman with an incidentally discovered renal mass measuring 2.3 × 2.2 × 1.8 cm?

Management of 2.3 cm Renal Mass in 74-Year-Old Female

For this 74-year-old woman with a 2.3 cm renal mass (cT1a), active surveillance should be the initial management approach given her age and the low oncologic risk of small renal masses, with intervention reserved only if tumor growth exceeds 0.5 cm/year or symptoms develop. 1

Initial Evaluation Required

Before making any treatment decision, complete the following workup:

• High-quality multiphase cross-sectional imaging (CT or MRI) to characterize the mass, assess enhancement pattern, and exclude fat content 1
• Comprehensive metabolic panel to assess baseline renal function and assign CKD stage 1
• Complete blood count and urinalysis 1
• Chest imaging to evaluate for metastases 1
• Consider renal mass biopsy for risk stratification, especially if results would influence the decision between surveillance and intervention 1, 2

Why Active Surveillance is Preferred at Age 74

The AUA guidelines explicitly state that active surveillance should be prioritized when anticipated risks of intervention or competing risks of death outweigh potential oncologic benefits 1. At 74 years old, this patient falls into the category where:

• Small renal masses (<2 cm) have particularly low oncologic risk 1
• Metastatic rates on surveillance are only 1-2% 1, 3
• Competing mortality from age-related comorbidities becomes increasingly relevant
• Decision analysis shows active surveillance becomes preferred when age exceeds 74 years 4

The most recent evidence from 2026 emphasizes that active surveillance is underutilized and radical approaches are overused in elderly patients, with competing comorbidities often outweighing oncologic risk 5, 6.

Active Surveillance Protocol

If surveillance is chosen, implement this specific schedule 1, 3:

1. Initial phase: Repeat imaging at 3-4 months, then at 6 months
2. Intermediate phase: Every 6 months until 3 years
3. Long-term phase: Annually thereafter
4. Imaging modality: CT, MRI, or ultrasound acceptable

Triggers for Delayed Intervention

Intervention should be considered if any of the following occur 1, 3:

• Tumor growth >0.5 cm/year (most important trigger)
• Maximum diameter exceeds 3-4 cm
• Development of symptoms (pain, hematuria)
• Patient preference changes after understanding risks

Alternative Treatment Options (If Intervention Indicated)

Should intervention become necessary or if the patient strongly prefers treatment despite counseling:

First-Line: Partial Nephrectomy

• Prioritize partial nephrectomy for cT1a masses when intervention is indicated 1
• Preserves renal function while providing definitive oncologic control
• Minimally invasive approach preferred when feasible 1

Second-Line: Thermal Ablation

• Consider thermal ablation for masses <3 cm, particularly at age 74 1
• Percutaneous approach preferred over surgical 1, 7
• Both radiofrequency ablation and cryoablation are acceptable options 1, 7
• Renal mass biopsy should be performed BEFORE ablation (not concomitantly) 1, 8, 7
• Accept higher local recurrence risk (can be retreated) versus surgical morbidity 1

Avoid: Radical Nephrectomy

• Should NOT be offered for a 2.3 cm mass unless anatomically impossible to preserve nephron 1
• Unnecessarily sacrifices renal function for minimal oncologic benefit

Critical Counseling Points

When discussing options with this patient, emphasize 1:

1. Low oncologic risk: Many small renal masses are indolent; 25% are benign, another 25% have limited metastatic potential 2
2. Competing mortality: At 74, other health conditions may pose greater risk than this small mass
3. Renal function preservation: Critical for long-term survival and quality of life
4. Surveillance safety: Oncologic outcomes are NOT compromised by initial surveillance if close follow-up is maintained 3
5. Delayed intervention remains feasible: Most patients on surveillance who eventually need treatment remain eligible for nephron-sparing approaches 3

Nephrology Referral Considerations

Refer to nephrology if 1:

• GFR <45 mL/min/1.73 m²
• Confirmed proteinuria present
• Diabetes with preexisting CKD
• Expected post-intervention GFR <30 mL/min/1.73 m²

Common Pitfalls to Avoid

1. Do not reflexively recommend surgery based solely on tumor presence—age and comorbidities matter more at 74 5, 6
2. Do not perform radical nephrectomy for a 2.3 cm mass—this represents overtreatment 1, 8
3. Do not skip renal mass biopsy if it would change management decisions 2, 8
4. Do not assume surveillance means "doing nothing"—it requires structured follow-up with defined intervention triggers 1, 3

The 2025 EAU guidelines and 2026 literature consistently support that individualized risk assessment integrating tumor size, growth kinetics, patient age, and life expectancy should guide management, with surveillance being the most appropriate initial approach for most patients over 74 with masses <3 cm 8, 5, 6, 9.